Related references
Note: Only part of the references are listed.The impact of carbapenem-resistant Pseudomonas aeruginosa on clinical and economic outcomes in a Chinese tertiary care hospital: A propensity score-matched analysis
Zhihui Chen et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2019)
Influence of bacterial resistance on mortality in intensive care units: a registry study from 2000 to 2013 (IICU Study)
V Bonnet et al.
JOURNAL OF HOSPITAL INFECTION (2019)
Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis
Alessandro Cassini et al.
LANCET INFECTIOUS DISEASES (2019)
Methods to systematically review and meta-analyse observational studies: a systematic scoping review of recommendations
Monika Mueller et al.
BMC MEDICAL RESEARCH METHODOLOGY (2018)
Multi-drug resistant organism infections in a medical ICU: Association to clinical features and impact upon outcome
E. E. Magira et al.
MEDICINA INTENSIVA (2018)
Economic burden of nosocomial infections caused by vancomycin-resistant enterococci
Laura Puchter et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2018)
Attributable Cost and Length of Stay Associated with Nosocomial Gram-Negative Bacterial Cultures
Richard E. Nelson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Intensive care unit-acquired pneumonia due to Pseudomonas aeruginosa with and without multidrug resistance
Laia Fernandez-Barat et al.
JOURNAL OF INFECTION (2017)
Misunderstandings about Q and 'Cochran's Q test' in meta-analysis
David C. Hoaglin
STATISTICS IN MEDICINE (2016)
Antimicrobial resistance-a threat to the world's sustainable development
Dusan Jasovsky et al.
UPSALA JOURNAL OF MEDICAL SCIENCES (2016)
Plea for routinely presenting prediction intervals in meta-analysis
Joanna IntHout et al.
BMJ OPEN (2016)
Resistance patterns and outcomes in intensive care unit (ICU)-acquired pneumonia. Validation of European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) classification of multidrug resistant organisms
Ignacio Martin-Loeches et al.
JOURNAL OF INFECTION (2015)
The impact of multidrug resistance on outcomes in ventilator-associated pneumonia
Rudy Tedja et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2014)
The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method
Joanna IntHout et al.
BMC MEDICAL RESEARCH METHODOLOGY (2014)
Hospital and Societal Costs of Antimicrobial-Resistant Infections in a Chicago Teaching Hospital: Implications for Antibiotic Stewardship
Rebecca R. Roberts et al.
CLINICAL INFECTIOUS DISEASES (2009)
Economic burden of healthcare-associated infections: an American perspective
Patricia W Stone
Expert Review of Pharmacoeconomics & Outcomes Research (2009)
The ratio of means method as an alternative to mean differences for analyzing continuous outcome variables in meta-analysis: A simulation study
Jan O. Friedrich et al.
BMC MEDICAL RESEARCH METHODOLOGY (2008)
Determinants and impact of multidrug antibiotic resistance in pathogens causing ventilator-associated-pneumonia
Pieter O. Depuydt et al.
CRITICAL CARE (2008)
Measuring the impact of multidrug resistance in nosocomial infection
Stijn Blot et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2007)
The power of the standard test for the presence of heterogeneity in meta-analysis
Dan Jackson
STATISTICS IN MEDICINE (2006)
Share Paper
